Filing Details

Accession Number:
0001209191-23-003146
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-12 16:29:04
Reporting Period:
2023-01-10
Accepted Time:
2023-01-12 16:29:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Therapeutics Public Ltd Co HZNP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1230482 W Jeffrey Sherman C/O Horizon Therapeutics Plc,
70 St. Stephen?S Green
Dublin L2 D02 E2X4
Evp And Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2023-01-10 3,368 $113.05 39,539 No 4 S Direct
Ordinary Shares Disposition 2023-01-11 3,368 $113.10 36,171 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 49,314 Indirect See Footnote
Ordinary Shares 84,430 Indirect See Footnote
Ordinary Shares 66,730 Indirect by Spouse
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2022.
  2. The shares are held in the Jeffrey W. Sherman Living Trust.
  3. The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee.